Effectiveness of low dose of gonadotropin releasing hormone agonist on hormonal flare-up

Journal of Assisted Reproduction and Genetics

Volumn 17, Issue 2, 2000, Pages 113-117

  Bständig, Bettina ^a   Cédrin Durnerin, Isabelle ^a   Hugues, Jean Noël ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Flare up; Gonadotropin releasing hormone agonist; Low dose; Short term IVF protocol

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; LUTEINIZING HORMONE; PROGESTERONE; TRIPTORELIN;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HORMONAL REGULATION; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HORMONES; HUMANS; LUTEINIZING HORMONE; NORETHINDRONE; PROGESTERONE; PROGESTERONE CONGENERS; TRIPTORELIN;

EID: 0343673871     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009470101732     Document Type: Article

References (21)

1. Hughes EG, Sagle MA, Federkow DM, Van de Koppel P, Daya S, Collins JA: The routine use of Gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992;58:888-896
2. Ben-Rafael Z, Lipitz S, Bider D, Mashiach S: Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels. Fertil Steril 1991;55:272-275
3. Testard J, Lefebvre B, Gougeon A: Effects of Gonadotropin-releasing hormone agonist (GnRHa) on follicle and oocyte quality. Hum Reprod 1993;8:511-518
4. Feldberg D, Farhi J, Ashkenazi J, Dicker D, Shalev J, Ben-Rafael Z: Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril 1994;62:343-346
5. Olivennes F, Righini C, Fanchin R, Torrisi C, Hazout A, Glissant M, Fernandez H, Frydman R: A protocol using a low dose of Gonadotropin-releasing hormone agonist might be the best protocol for patients with high follicle stimulation hormone concentrations on day 3. Hum Reprod 1996;11:169-1172
6. Scott RT, Navot D: Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 1994;6:880-885
7. Schoolcraft W, Schenker T, Stevens J, Wagley L, Gee M: Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol. Fertil Steril 1997;67:93-97
8. Surrey ES, Brower JA, Hill DM, Ramsey J, Surrey MW: Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 1998;69:419-424
9. Sandow J, Donnez J: Clinical pharmacokinetics of LHRH analogues. In LHRH Analogues in Gynecology, I Brosens, HS Jacobs, B Runnebaum (eds), Carnforth, UK Pathernon Publishing, 1990, pp 17-31
10. Broekmans FG, Hompes PGA, Lambalk CB, Shoute E, Breeders A, Schoemaker J: Short term pitutary desensitization: effects of different doses of the gonadotrophin-releasing hormone agonist triptorelin. Hum Reprod 1996;11:55-60
11. Janssens RMJ, Vermeiden JPW, Lambalk CB, Shats R, Schoemaker J: Gonadotrophin-releasing hormone agonist dose-dependency of pituitary desensitization during controlled of ovarian hyperstimulation in IVF. Hum Reprod 1998;13:2386-2391
12. Cédrin-Durnerin I, Bulwa S, Hervé F, Martin-Pont B, Uzan M, Hugues JN: The hormonal flare-up following gonadotropin-releasing hormone agonist administration is influenced by a progestogen pretreatment. Hum Reprod 1996;11:1859-1863
13. Lemay A, Metha AE, Tolis G, Faure N, Labrie F, Fazekas ATA: Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phase. Fertil Steril 1983;39:668-673
14. Navot D, Rosenwaks Z, Anderson F, Hodgen GD: Gonadotropin-releasing hormone agonist induced ovarian hyperstimulation: Low-dose side effects in women and monkeys. Fertil Steril 1991;55:1069-1075
15. Deaton JL, Bauguess P, Huffman CS, Miller KA: Pituitary response to early follicular-phase minidose gonadotropin releasing hormone agonist (GnRHa) therapy: evidence for a second flare. J Assist Reprod Genet 1996;13:390-394
16. Scott RT, Carey KD, Leland M, Navot D: Gonadotropin responsiveness to ultralow-dose leuprolide acetate administration in baboons. Fertil Steril 1993;59:1124-1128
17. Hugues JN, Attalah M, Hervé F, Martin-Pont B, Kottler ML, Santarelli J: Effects of short-term GnRH agonist human menopausal Gonadotropin stimulation in patients pre-treated with progestogen. Hum Reprod 1992;7:1079-1084
18. Weil SJ, Vendola k, Zhou J, Adesanya OO, Wang J, Okafor J, Bondy CA: Androgen Receptor Gene Expression in the Primate Ovary: Cellular Localization, Regulation, and Functional Correlations. J Clin Endocrinol Metab 1998;83:2479-2485
19. Bergh C, Howles CM, Borg K, Hamberger LH, Josefsson B, Nilsson L, Wikland M: Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): Results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod 1997;12:2133-2139
20. Brzyski RG, Muasher SJ, Froesch K, Simonetti S, Jones GS, Rosenwaks Z: Follicular atresia associated with concurent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitement. Fertil Steril 1988;50:917-921
21. Loumaye E, Wankrieken L, Depreester S, Psalti I, de Coonan S, Thomas K: Hormonal changes by short-term administration of a gonadotropin-releasing hormone agonist during ovarian hyper-stimulation for in vitro fertilization and their consequences for embryonic development. Fertil Steril 1989;51:105-111